Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation.
Although, the most common Cystic Fibrosis mutation, ΔF508, in the cystic fibrosis transmembrane regulator. (CFTR), is located in nucleotide binding domain (NBD1), disease-causing mutations also occur in NBD2. To provide information on potential therapeutic strategies for mutations in NBD2, we studie...
Main Authors: | Daniele Rapino, Inna Sabirzhanova, Miquéias Lopes-Pacheco, Rahul Grover, William B Guggino, Liudmila Cebotaru |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0119796 |
Similar Items
-
Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis
by: Miquéias Lopes-Pacheco, et al.
Published: (2017-04-01) -
The CFTR Corrector, VX-809 (Lumacaftor), Rescues ABCA4 Trafficking Mutants: a Potential Treatment for Stargardt Disease
by: Qiangni Liu, et al.
Published: (2019-08-01) -
Restoration of F508-del Function by Transcomplementation: The Partners Meet in the Endoplasmic Reticulum
by: Emily Anne Smith Bergbower, et al.
Published: (2019-04-01) -
The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis
by: Emily Bergbower, et al.
Published: (2018-01-01) -
Correcting the cystic fibrosis disease mutant, A455E CFTR.
by: Liudmila Cebotaru, et al.
Published: (2014-01-01)